These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26829032)

  • 1. Opposing Roles of JNK and p38 in Lymphangiogenesis in Melanoma.
    Puujalka E; Heinz M; Hoesel B; Friedl P; Schweighofer B; Wenzina J; Pirker C; Schmid JA; Loewe R; Wagner EF; Berger W; Petzelbauer P
    J Invest Dermatol; 2016 May; 136(5):967-977. PubMed ID: 26829032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis.
    Kobayashi S; Kishimoto T; Kamata S; Otsuka M; Miyazaki M; Ishikura H
    Cancer Sci; 2007 May; 98(5):726-33. PubMed ID: 17425689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
    Špirić Z; Eri Ž; Erić M
    Int J Surg Pathol; 2015 Dec; 23(8):629-37. PubMed ID: 25911567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells.
    Li J; Chen Y; Zhang L; Xing L; Xu H; Wang Y; Shi Q; Liang Q
    J Ethnopharmacol; 2016 Dec; 193():293-302. PubMed ID: 27553977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-27b through a CaMKII/AMPK/p38 signaling pathway in human chondrosarcoma cells.
    Huang CY; Chang AC; Chen HT; Wang SW; Lo YS; Tang CH
    Clin Sci (Lond); 2016 Sep; 130(17):1523-33. PubMed ID: 27252405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetraspanin CD9 induces MMP-2 expression by activating p38 MAPK, JNK and c-Jun pathways in human melanoma cells.
    Hong IK; Kim YM; Jeoung DI; Kim KC; Lee H
    Exp Mol Med; 2005 Jun; 37(3):230-9. PubMed ID: 16000878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MET expression in melanoma correlates with a lymphangiogenic phenotype.
    Swoboda A; Schanab O; Tauber S; Bilban M; Berger W; Petzelbauer P; Mikula M
    Hum Mol Genet; 2012 Aug; 21(15):3387-96. PubMed ID: 22570180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
    Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual c-Jun N-terminal kinase-cyclin D1 and extracellular signal-related kinase-c-Jun disjunction in human melanoma.
    Pathria G; Garg B; Garg K; Wagner C; Wagner SN
    Br J Dermatol; 2016 Dec; 175(6):1221-1231. PubMed ID: 27145925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis signal-regulating Kinase 1 by E2F-1 may not be essential for E2F-1-mediated apoptosis in melanoma cells.
    Dong YB; Phelps AM; Yang HL; Jamshidi-Parsian A; Chen C; Hao H; Gomez-Gutierrez JG; Zhou HS; McMasters KM
    Tumour Biol; 2007; 28(2):111-22. PubMed ID: 17287612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
    Leo V; Stefanachi A; Nacci C; Leonetti F; de Candia M; Carotti A; Altomare CD; Montagnani M; Cellamare S
    J Pharm Pharmacol; 2015 Oct; 67(10):1380-92. PubMed ID: 26078032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck.
    Luangdilok S; Box C; Harrington K; Rhŷs-Evans P; Eccles S
    Eur J Cancer; 2011 Mar; 47(4):520-9. PubMed ID: 21074412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis.
    Bracher A; Cardona AS; Tauber S; Fink AM; Steiner A; Pehamberger H; Niederleithner H; Petzelbauer P; Gröger M; Loewe R
    J Invest Dermatol; 2013 Jan; 133(1):230-8. PubMed ID: 22951723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway.
    Mhaidat NM; Zhang XD; Jiang CC; Hersey P
    Clin Cancer Res; 2007 Feb; 13(4):1308-14. PubMed ID: 17317842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative regulation by p70 S6 kinase of FGF-2-stimulated VEGF release through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
    Takai S; Tokuda H; Hanai Y; Harada A; Yasuda E; Matsushima-Nishiwaki R; Kato H; Ogura S; Ohta T; Kozawa O
    J Bone Miner Res; 2007 Mar; 22(3):337-46. PubMed ID: 17181399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanoma.
    Jørgensen K; Davidson B; Flørenes VA
    Mod Pathol; 2006 Nov; 19(11):1446-55. PubMed ID: 16951673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt1 is anti-lymphangiogenic in a melanoma mouse model.
    Niederleithner H; Heinz M; Tauber S; Bilban M; Pehamberger H; Sonderegger S; Knöfler M; Bracher A; Berger W; Loewe R; Petzelbauer P
    J Invest Dermatol; 2012 Sep; 132(9):2235-44. PubMed ID: 22572818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-κB/JNK pathways in colorectal cancer.
    Zhu G; Huang Q; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Wang J; Ye J
    Oncotarget; 2016 Nov; 7(45):73711-73724. PubMed ID: 27713159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical markers and driving mechanisms in melanoma progression: VEGF-C, RhoC, c-Ski/SnoN and EGFR.
    Boone B; Brochez L
    Verh K Acad Geneeskd Belg; 2009; 71(5):251-94. PubMed ID: 20232784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.